These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30187709)

  • 21. Chronic mucocutaneous candidiasis due to gain-of-function mutation in STAT1.
    Carey B; Lambourne J; Porter S; Hodgson T
    Oral Dis; 2019 Apr; 25(3):684-692. PubMed ID: 29702748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human STAT1 Gain-of-Function Heterozygous Mutations: Chronic Mucocutaneous Candidiasis and Type I Interferonopathy.
    Okada S; Asano T; Moriya K; Boisson-Dupuis S; Kobayashi M; Casanova JL; Puel A
    J Clin Immunol; 2020 Nov; 40(8):1065-1081. PubMed ID: 32852681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-cell RNA sequencing combined with whole exome sequencing reveals the landscape of the immune pathogenic response to chronic mucocutaneous candidiasis with STAT1 GOF mutation.
    Lu X; Zhang K; Jiang W; Li H; Huang Y; Du M; Wan J; Cao Y; Du L; Liu X; Pan W
    Front Immunol; 2022; 13():988766. PubMed ID: 36225936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pathogenic T387A missense mutation in the gene encoding signal transducer and activator of transcription 1 exhibits a differential gene expression profile.
    Staab J; Schwämmle T; Meyer T
    Mol Immunol; 2020 Dec; 128():79-88. PubMed ID: 33096415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel gain-of-function STAT1 mutation resulting in basal phosphorylation of STAT1 and increased distal IFN-γ-mediated responses in chronic mucocutaneous candidiasis.
    Martinez-Martinez L; Martinez-Saavedra MT; Fuentes-Prior P; Barnadas M; Rubiales MV; Noda J; Badell I; Rodríguez-Gallego C; de la Calle-Martin O
    Mol Immunol; 2015 Dec; 68(2 Pt C):597-605. PubMed ID: 26514428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ruxolitinib treatment of a patient with steroid-dependent severe autoimmunity due to STAT1 gain-of-function mutation.
    Moriya K; Suzuki T; Uchida N; Nakano T; Katayama S; Irie M; Rikiishi T; Niizuma H; Okada S; Imai K; Sasahara Y; Kure S
    Int J Hematol; 2020 Aug; 112(2):258-262. PubMed ID: 32180118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired natural killer cell functions in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations.
    Tabellini G; Vairo D; Scomodon O; Tamassia N; Ferraro RM; Patrizi O; Gasperini S; Soresina A; Giardino G; Pignata C; Lougaris V; Plebani A; Dotta L; Cassatella MA; Parolini S; Badolato R
    J Allergy Clin Immunol; 2017 Aug; 140(2):553-564.e4. PubMed ID: 28069426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Relevance of Gain- and Loss-of-Function Germline Mutations in STAT1: A Systematic Review.
    Zhang W; Chen X; Gao G; Xing S; Zhou L; Tang X; Zhao X; An Y
    Front Immunol; 2021; 12():654406. PubMed ID: 33777053
    [No Abstract]   [Full Text] [Related]  

  • 29. Case report: Myocarditis in congenital STAT1 gain-of function.
    Staels F; Roosens W; Giovannozzi S; Moens L; Bogaert J; Iglesias-Herrero C; Gijsbers R; Bossuyt X; Frans G; Liston A; Humblet-Baron S; Meyts I; Van Aelst L; Schrijvers R
    Front Immunol; 2023; 14():1095595. PubMed ID: 37020552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human STAT1 gain of function with chronic mucocutaneous candidiasis: A comprehensive review for strengthening the connection between bedside observations and laboratory research.
    Asano T; Noma K; Mizoguchi Y; Karakawa S; Okada S
    Immunol Rev; 2024 Mar; 322(1):81-97. PubMed ID: 38084635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gain-of-function STAT1 mutations are associated with intracranial aneurysms.
    Dadak M; Jacobs R; Skuljec J; Jirmo AC; Yildiz Ö; Donnerstag F; Baerlecken NT; Schmidt RE; Lanfermann H; Skripuletz T; Schwenkenbecher P; Kleinschnitz C; Tumani H; Stangel M; Pul R
    Clin Immunol; 2017 May; 178():79-85. PubMed ID: 28161409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunophenotyping and Therapeutic Insights from Chronic Mucocutaneous Candidiasis Cases with STAT1 Gain-of-Function Mutations.
    Lei WT; Lo YF; Tsumura M; Ding JY; Lo CC; Lin YN; Wang CW; Liu LH; Shih HP; Peng JJ; Wu TY; Chan YP; Kang CX; Wang SY; Kuo CY; Tu KH; Yeh CF; Hsieh YJ; Asano T; Chung WH; Okada S; Ku CL
    J Clin Immunol; 2024 Aug; 44(8):184. PubMed ID: 39177867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simple diagnosis of STAT1 gain-of-function alleles in patients with chronic mucocutaneous candidiasis.
    Mizoguchi Y; Tsumura M; Okada S; Hirata O; Minegishi S; Imai K; Hyakuna N; Muramatsu H; Kojima S; Ozaki Y; Imai T; Takeda S; Okazaki T; Ito T; Yasunaga S; Takihara Y; Bryant VL; Kong XF; Cypowyj S; Boisson-Dupuis S; Puel A; Casanova JL; Morio T; Kobayashi M
    J Leukoc Biol; 2014 Apr; 95(4):667-76. PubMed ID: 24343863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biallelic TRAF3IP2 variants causing chronic mucocutaneous candidiasis in a child harboring a STAT1 variant.
    Blanco Lobo P; Lei WT; Pelham SJ; Guisado Hernández P; Villaoslada I; de Felipe B; Lucena JM; Casanova JL; Olbrich P; Puel A; Neth O
    Pediatr Allergy Immunol; 2021 Nov; 32(8):1804-1812. PubMed ID: 34289170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. STAT1 gain-of-function and chronic demodicosis.
    Molho-Pessach V; Meltser A; Kamshov A; Ramot Y; Zlotogorski A
    Pediatr Dermatol; 2020 Jan; 37(1):153-155. PubMed ID: 31637766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic mucocutaneous candidiasis caused by a gain-of-function mutation in the STAT1 DNA-binding domain.
    Takezaki S; Yamada M; Kato M; Park MJ; Maruyama K; Yamazaki Y; Chida N; Ohara O; Kobayashi I; Ariga T
    J Immunol; 2012 Aug; 189(3):1521-6. PubMed ID: 22730530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary immunodeficiency and chronic mucocutaneous candidiasis: pathophysiological, diagnostic, and therapeutic approaches.
    Egri N; Esteve-Solé A; Deyà-Martínez À; Ortiz de Landazuri I; Vlagea A; García AP; Cardozo C; Garcia-Vidal C; Bartolomé CS; Español-Rego M; Yiyi L; Bosch-Amate X; Ferrando J; Yagüe J; Juan M; Alsina L
    Allergol Immunopathol (Madr); 2021; 49(1):118-127. PubMed ID: 33528939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a distinct subset of disease-associated gain-of-function missense mutations in the STAT1 coiled-coil domain as system mutants.
    Petersen J; Staab J; Bader O; Buhl T; Ivetic A; Meyer T
    Mol Immunol; 2019 Oct; 114():30-40. PubMed ID: 31336247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic mucocutaneous candidiasis: characterization of a family with STAT-1 gain-of-function and development of an ex-vivo assay for Th17 deficiency of diagnostic utility.
    Dhalla F; Fox H; Davenport EE; Sadler R; Anzilotti C; van Schouwenburg PA; Ferry B; Chapel H; Knight JC; Patel SY
    Clin Exp Immunol; 2016 May; 184(2):216-27. PubMed ID: 26621323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoprofiling of monocytes in STAT1 gain-of-function chronic mucocutaneous candidiasis.
    Bloomfield M; Zentsova I; Milota T; Sediva A; Parackova Z
    Front Immunol; 2022; 13():983977. PubMed ID: 36172362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.